E. Bilianou
Publications by Year
Research Areas
Lipoproteins and Cardiovascular Health, Cancer, Lipids, and Metabolism, Diabetes, Cardiovascular Risks, and Lipoproteins, Atrial Fibrillation Management and Outcomes, Diabetes Treatment and Management
Most-Cited Works
- → Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible Diabetes (ATTEMPT): A Prospective-Randomized Study in Middle Aged Men and Women(2011)50 cited
- → Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors(2016)30 cited
- → Long-Term Impact of Multifactorial Treatment on New-Onset Diabetes and Related Cardiovascular Events in Metabolic Syndrome(2011)26 cited
- → l‐Carnitine/Simvastatin Reduces Lipoprotein (a) Levels Compared with Simvastatin Monotherapy: A Randomized Double‐Blind Placebo‐Controlled Study(2016)22 cited
- → An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)(2017)18 cited
- → Cardiovascular disease in women: Executive summary of the expert panel statement of women in cardiology of the hellenic cardiological society(2020)18 cited
- → Achieving low-density lipoprotein cholesterol targets as assessed by different methods in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH registry(2020)12 cited
- → The Prognostic Significance of Atrial Arrhythmias Recorded Early After Cardioversion for Atrial Fibrillation(2001)12 cited
- → Prevalence of Diabetes and Its Association with Atherosclerotic Cardiovascular Disease Risk in Patients with Familial Hypercholesterolemia: An Analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)(2022)7 cited